<乌鸦传媒>TNF Inhibitors for IBD Linked to Kidney Function Declines Observational VA data support recommendations for monitoring with initiation Apr 16, 2024
<乌鸦传媒>Can an Autoimmunity Lead to Immune Deficiency? Studies may explain some cases of rare opportunistic infections Mar 20, 2024
<乌鸦传媒>Valley Fever Screens Found Lagging for Rheum Patients in Endemic Areas A significant issue for DMARD and steroid users in the American Southwest Mar 14, 2024
<乌鸦传媒>Risankizumab Beats Ustekinumab for Previously Treated Crohn's The IL-23 inhibitor led to more clinical remissions vs the IL-12/23 inhibitor Feb 26, 2024
<乌鸦传媒>Top-Down Treatment Superior to Step-Up Approach for Crohn's Disease Early intensive treatment should be standard for most patients, researchers argue Feb 26, 2024
<乌鸦传媒>AGA Backs Fecal Microbiota-Based Therapies for Recurrent C. Diff But new guidelines do not recommend use in inflammatory bowel disease or irritable bowel syndrome Feb 21, 2024
<乌鸦传媒>Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD Patients with ulcerative colitis and Crohn's also experienced improved clinical remission Feb 02, 2024
<乌鸦传媒>History of IBD Linked to Severe Outcomes in Patients Hospitalized for COVID IBD was associated with an increased risk of sepsis, shock, and acute kidney injury Feb 01, 2024
<乌鸦传媒>IBD Surgery Linked to Improved Patient-Reported Pain, Physical Health However, this was not the case for social, emotional outcomes Jan 31, 2024
<乌鸦传媒>Telehealth Option Increased IBD Clinic's Patient Retention More than 60% of patients had return IBD care delivered via telehealth Jan 30, 2024
<乌鸦传媒>Switching Twice With Infliximab Biosimilars Not Linked With IBD Flare Risk Reassuring findings for patients whose insurance requires a switch Jan 28, 2024
<乌鸦传媒>Early Anti-TNF Reduces Perianal Fistula Risk in Kids With Crohn's "Far better to prevent these complications than to treat them once they occur," says researcher Jan 28, 2024
<乌鸦传媒>Clinical Challenges: Integrating Diet Into Crohn's Disease Management Whole-foods dietary patterns should complement therapeutic regimens Dec 27, 2023
<乌鸦传媒>Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomes However, avoiding pregnancy when on the IBD/MS drug still advised Dec 19, 2023
<乌鸦传媒>Novel Oral Agent May Dial Down Ulcerative Colitis Severity Investigational drug missed primary endpoint, but yielded durable responses in early trial Dec 18, 2023
<乌鸦传媒>Shingles Vaccine Reduced Zoster Attacks in Patients With IBD Patients 50 and older saw benefits with vaccine, except in cases of complicated zoster Dec 18, 2023
<乌鸦传媒>Goodbye, Appendix. Hello, Crohn's Disease? Meta-analysis finds a possible connection, although high heterogeneity was an issue Dec 17, 2023
<乌鸦传媒>Red Meat Consumption Tied to Higher Chance of UC Flare But similar association not seen for other high fat foods Dec 17, 2023
<乌鸦传媒>National Database Study Finds Higher Risk for Barrett鈥檚 Esophagus in IBD But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
<乌鸦传媒>Methotrexate Tied to Greater Risks for Older Patients With CKD FDA should consider warning labels based on study results, researchers argue Nov 28, 2023
<乌鸦传媒>Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events Newer agents also associated with lower VTE risk versus non-advanced treatments Nov 28, 2023 video
<乌鸦传媒>How to Position the Growing Number of Therapies in IBD "Exciting time" to treat Crohn's disease and ulcerative colitis, expert says Nov 21, 2023 video
<乌鸦传媒>New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks More than half of patients not in early clinical response at week 12 responded by week 24 Nov 14, 2023 video
<乌鸦传媒>Stelara Biosimilar OK'd With Interchangeability But patent settlement may keep new product off market until 2025 Nov 01, 2023
<乌鸦传媒>Controversial Kratom Appeared to Cause Severe Ulcerative Colitis Flare Researchers strongly discourage its use in IBD patients Oct 24, 2023
<乌鸦传媒>New Oral Drug Approved for Ulcerative Colitis in Adults S1P receptor modulator etrasimod indicated for moderately to severely active disease Oct 13, 2023
<乌鸦传媒>Atopic Dermatitis Linked to Increased IBD Risk in Adults and Kids Risk increased with severity of atopic dermatitis across both groups, cohort study shows Aug 30, 2023
<乌鸦传媒>U.S. Unveils First 10 Drugs for Medicare Price Negotiations Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
<乌鸦传媒>Doctors, Patients Try to Shame Insurers to Reverse Prior Auth Denials Many have taken to social media to get tests, drugs, and treatments approved Aug 27, 2023
<乌鸦传媒>First Multiple Sclerosis Biosimilar Approved Natalizumab-sztn gets a nod from the FDA Aug 25, 2023
<乌鸦传媒>TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases "Paradoxical" finding puzzles researchers Jul 22, 2023
<乌鸦传媒>Mirikizumab Benefit in UC Extends Into Maintenance Phase Twice as many responders achieved clinical remission at week 40 versus placebo Jun 28, 2023
<乌鸦传媒>Inflammatory Bowel Disease Linked With Increased Stroke Risk Swedish study is largest, with longest follow-up to date Jun 14, 2023
<乌鸦传媒>A Close Look at the Data Backing Upadacitinib's Approval in Crohn's Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response May 25, 2023
<乌鸦传媒>First JAK Inhibitor Approved for Crohn's Disease Upadacitinib lands indication for moderately to severely active disease in adults May 18, 2023
<乌鸦传媒>Win for Vedolizumab in Recurrent Crohn's Disease Trial boosts case for label expansion May 08, 2023
<乌鸦传媒>Vedolizumab Proves Its Worth in Treating Chronic Pouchitis Biologic effective for common complication of ileal pouch-anal anastomosis in ulcerative colitis Mar 29, 2023
<乌鸦传媒>IL-6 Inhibitor for UC Shows Some Promise in Mid-Stage Trial Though next steps for olamkicept in ulcerative colitis a bit unclear Mar 07, 2023
<乌鸦传媒>Tyler James Williams' Crohn's Disease Golden Globe winner talks about his health ordeal Jan 25, 2023
